Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$87,102 Mln
P/E Ratio
31.85
P/B Ratio
5.04
Industry P/E
28.06
Debt to Equity
-3.75
ROE
0 %
ROCE
55.3 %
Div. Yield
0.41 %
Book Value
--
EPS
21.82
CFO
$41,554.00 Mln
EBITDA
$40,794.00 Mln
Net Profit
$11,403.00 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
McKesson (MCK)
| 22.78 | 5.12 | 15.77 | 28.79 | 30.09 | 37.32 | 11.91 |
|
BSE Sensex*
| 2.63 | 3.74 | 5.81 | 8.92 | 11.77 | 20.12 | 11.35 |
|
S&P 100
| -7.89 | -2.87 | -8.61 | 10.75 | 12.08 | 15.20 | 11.21 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
McKesson (MCK)
| 22.89 | 23.42 | 50.91 | 42.92 | 25.74 | 25.21 | -29.03 |
|
S&P 100
| 29.04 | 30.83 | -22.12 | 27.55 | 19.30 | 29.47 | -5.82 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 192.34 | 329,136.41 | 78.18 | 62.52 | |
| 877.29 | 794,307.13 | 75.73 | 84.41 | |
| 155.35 | 372,772.77 | 17.18 | 29.42 | |
| 83.19 | 208,206.09 | 12.03 | 40.81 |
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S.... Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas. Address: 6555 State Highway 161, Irving, TX, United States, 75039 Read more
CEO & Director
Mr. Brian S. Tyler Ph.D.
Executive VP & CFO
Mr. Britt J. Vitalone
Headquarters
Irving, TX
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of McKesson Corporation (MCK) stood at $ 129,643 Mln as on 31-Dec-24
The share price of McKesson Corporation (MCK) is $699.73 (NYSE) as of 28-Apr-2025 16:10 EDT. McKesson Corporation (MCK) has given a return of 30.09% in the last 3 years.
McKesson Corporation (MCK) has a market capitalisation of $ 87,102 Mln as on 28-Apr-2025. As per Value Research classification, it is a Large Cap company.
The P/B ratio of McKesson Corporation (MCK) is 5.04 times as on 28-Apr-2025, a 0% premium to its peers’ median range of 5.04 times.
The P/E ratio of McKesson Corporation (MCK) is 31.85 times as on 28-Apr-2025, a 14% premium to its peers’ median range of 28.06 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the McKesson Corporation (MCK) and enter the required number of quantities and click on buy to purchase the shares of McKesson Corporation (MCK).
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas. Address: 6555 State Highway 161, Irving, TX, United States, 75039
The CEO & director of Mr. Brian S. Tyler Ph.D.. is McKesson Corporation (MCK), and CFO & Sr. VP is Mr. Britt J. Vitalone.
There is no promoter pledging in McKesson Corporation (MCK).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
74,481
|
|
|
38,015
|
|
|
31,320
|
|
|
19,872
|
| McKesson Corporation (MCK) | Ratios |
|---|---|
|
Return on equity(%)
|
--
|
|
Operating margin(%)
|
1.25
|
|
Net Margin(%)
|
0.82
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of McKesson Corporation (MCK) was $0 Mln.
$4.73
(
